title: Phenobarbital blockade of the preovulatory luteinizing hormone surge: association with phase-advanced circadian clock and altered suprachiasmatic nucleus Period1 gene expression.
abstract: The suprachiasmatic nucleus (SCN) controls the timing of the preovulatory luteinizing hormone (LH) surge in laboratory rodents. Barbiturate administration during a critical period on proestrus delays the surge and prolongs the estrous cycle 1 day. Because a nonphotic timing signal (zeitgeber) during the critical period that phase advances activity rhythms can also induce the latter effect, we hypothesized that barbiturates delay the LH surge by phase-advancing its circadian timing signal beyond the critical period. In experiment 1, locomotor rhythms and estrous cycles were monitored in hamsters for 2-3 wk preinjection and postinjection of vehicle or phenobarbital and after transfer to darkness at zeitgeber time (ZT) 6 on proestrus. Phenobarbital delayed estrous cycles in five of seven hamsters, which exhibited phase shifts that averaged twofold greater than those exhibited by vehicle controls or phenobarbital-injected hamsters with normal cycles. Experiment 2 used a similar protocol, but injections were at ZT 5, and blood samples for LH determination were collected from 1200 to 1800 on proestrus and the next day via jugular cannulae inserted the day before proestrus. Phenobarbital delayed the LH surge 1 day in all six hamsters, but it occurred at an earlier circadian time, supporting the above hypothesis. Experiment 3 investigated whether phenobarbital, like other nonphotic zeitgebers, suppresses SCN Period1 and Period2 transcription. Two hours postinjection, phenobarbital decreased SCN expression of only Period1 mRNA, as determined by in situ hybridization. These results suggest that phenobarbital advances the SCN pacemaker, governing activity rhythms and hormone release in part by decreasing its Period1 gene expression.
authors.affiliation: Department of Physiology, University of Kentucky Medical Center, Lexington, KY 40536-0298, USA. sjlegan@uky.edu
authors.forename: Sandra J
authors.initials: SJ
authors.lastname: Legan
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Donoghue
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Franklin
authors.forename: Marilyn J
authors.initials: MJ
authors.lastname: Duncan
mesh_terms: D000818:Animals; D002940:Circadian Rhythm / Q000502:physiology*; D006224:Cricetinae; D030762:Estrous Cycle / Q000187:drug effects; D005260:Female; D005498:Follicular Phase / Q000378:metabolism*; D018757:GABA Modulators / Q000494:pharmacology*; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D008124:Locomotion / Q000187:drug effects; D007986:Luteinizing Hormone / Q000378:metabolism*; D008647:Mesocricetus; D056950:Period Circadian Proteins; D010634:Phenobarbital / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D013493:Suprachiasmatic Nucleus / Q000378:metabolism*
chemical_list: D018757:GABA Modulators; D047908:Intracellular Signaling Peptides and Proteins; D056950:Period Circadian Proteins; D012333:RNA, Messenger; D007986:Luteinizing Hormone; D010634:Phenobarbital